Login / Signup

Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years.

Annie HawtonElizabeth GoodwinKate BoddyJennifer FreemanSarah ThomasJeremy ChatawayColin Green
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)
We conclude by highlighting methodological and policy developments which should aid addressing these limitations.
Keyphrases
  • multiple sclerosis
  • public health
  • healthcare
  • mental health
  • white matter
  • quality improvement